Full Text View
Tabular View
No Study Results Posted
Related Studies
Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions
This study has been completed.
Study NCT00775255   Information provided by Ranbaxy Inc.

First Received on October 16, 2008.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial